Catalyst Biosciences Annual Revenue, Competitors, Number of Employees and Funding

Claim your profile

Overview

Location:
Total Funding:$94.3M
Industry:Biotech
Founded:N/A
Lead Investor(s):JonesTrading Institutional Services LLC
Press
Claim your profile

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Catalyst Biosciences's estimated annual revenue is currently $0M per year.
  • Catalyst Biosciences received $115.0M in venture funding in February 2018.
  • Catalyst Biosciences's estimated revenue per employee is $120
  • Catalyst Biosciences's total funding is $94.3M.

Employee Data

  • Catalyst Biosciences has 50 Employees.
  • Catalyst Biosciences grew their employee count by 25% last year.
  • Catalyst Biosciences currently has 6 job openings.

Executive Contacts

NameTitleEmail
Nassim UsmanPresident & Ceo, Member Board Of DirectorsEmail Available
April YamadaAccounts Payable Manager
Jen WilsonDirector, Project ManagementEmail Available
Janet HillmanSenior Director ProjectEmail Available
Laura SzewcyzkClinical Trial Manager, Hematology
Anju ChatterjiDirector, Technical Development
Fletcher PayneCFOEmail Available
Sue FerminInterim Accounting Manager
Faisal ShawwaCompliance Officer & Executive Director, FinanceEmail Available
Andy HoweSr. Director Quality Assurance

Catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. We used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. Learn more about Our Hemophilia Program. A protease is an enzyme that cleaves target proteins. Learn more about Proteases.

keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power

50

Number of Employees

$0M

Revenue (est)

6

Current Jobs

25%

Employee Growth %

$94.3M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
DiaCarta
$6.7M4310%N/A
Mission Bio
$11.5M7445%N/A
Rigel Pharmaceu...
$45M2904%N/A
ProTrials Resea...
$28.2M1823%N/A
Trace Genomics
$6.4M4137%N/A
Advanced Cell D...
$27.6M1788%N/A
CellMax Life
$6.2M4011%N/A
Vaxart
$4.2M33-15%N/A
Full Spectrum A...
$6.5M425%N/A
Calysta
$7.6M49-2%N/A
Missing a competitor? Contribute!?
Submit

Catalyst Biosciences News

09/03/2019 - Catalyst Biosciences to Present at the 2019 ASBMB ...

Catalyst Biosciences to Present at the 2019 ASBMB Symposium on Serine Proteases in Pericellular Proteolysis and Signaling Conference ...

09/08/2019 - Catalyst Biosciences to Present at the 2019 Hemophilia Drug ...

SOUTH SAN FRANCISCO, Calif., Aug. 16, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced an oral ...

09/03/2019 - Catalyst Biosciences Announces Transition of Chief Financial ...

SOUTH SAN FRANCISCO, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced that its ...

Catalyst Biosciences Funding

DateAmountRoundLead InvestorsReference
2004-10-29$10.3MASofinnova VeArticle
2006-02-10$30.0MBMorgenthaler VenturesArticle
2008-12-04$40.4MCEssex Woodlands Health VentureArticle
2012-01-09$7.0MUndisclosedPfizerArticle
2017-04-10$20.7MUndisclosedLadenburg Thalmann & Co. IncArticle
2017-12-22$10.5MUndisclosedJonesTrading Institutional Services LLCArticle
2018-02-14$115.0MUndisclosedJonesTrading Institutional Services LLCArticle

Catalyst Biosciences Executive Hires

DateNameTitleReference
2005-03-09Title: David J. O'ReillyPresidentArticle
2006-02-13Edwin MadisonChief Scientific OfficerArticle
2006-02-23Nassim UsmanCEOArticle
2006-05-24Marc NavreVP Drug DiscoveryArticle
2007-02-02Erik WibergChief Financial OfficerArticle
2008-10-29Todd LorenzChief Medical OfficerArticle
2010-03-03William J. DawsonCFOArticle
2017-02-17Andrew HetheringtonSVP Technical OperationsArticle

Catalyst Biosciences Staff Cuts

DateNumber of EmployeesLocationReference
2016-09-0810Article